Montag & Associates’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-425
Closed -$1K 883
2022
Q2
$1K Hold
425
﹤0.01% 799
2022
Q1
$1K Hold
425
﹤0.01% 818
2021
Q4
$2K Hold
425
﹤0.01% 799
2021
Q3
$2K Hold
425
﹤0.01% 797
2021
Q2
$2K Hold
425
﹤0.01% 788
2021
Q1
$2K Hold
425
﹤0.01% 793
2020
Q4
$2K Buy
+425
New +$1.77K ﹤0.01% 769
2019
Q1
Sell
-24,350
Closed -$73K 314
2018
Q4
$73K Sell
24,350
-43,940
-64% -$149K 0.01% 285
2018
Q3
$236K Buy
+68,290
New +$363K 0.02% 298

Other funds holding OPK

Montag & Associates's OPK Position: Q3 2022 in Review

Montag & Associates sold out of Opko Health (OPK) in Q3 2022, closing a stake of 425 shares — an estimated $1K sold.

Montag & Associates first reported a position in OPK in Q3 2018 and held it in 9 quarters. The position peaked at $236K in Q3 2018. 221 funds tracked by Wall St. Rank hold OPK as of Q3 2022.

  • Montag & Associates reported no remaining Opko Health position as of Q3 2022 after selling out during the quarter.
  • Montag & Associates sold 425 Opko Health shares in Q3 2022, an estimated $1K.
  • Montag & Associates first reported a position in Opko Health in Q3 2018 and held it in 9 quarters.
  • Montag & Associates's Opko Health position peaked at $236K in Q3 2018.
  • 221 funds tracked by Wall St. Rank held Opko Health as of Q3 2022.

Based on Montag & Associates's 13F filing for Q3 2022, filed 9 Nov 2022.